Kristina Torfgård
Vice President, Clinical Development
Business development
Albireo
Sweden
Biography
Kristina Torfgård has more than 20 years of experience in drug development covering the full product lifecycle and spanning multiple therapeutic and disease areas, including gastrointestinal, neuroscience, cardiovascular and metabolic disease/diabetes. Prior to joining Albireo, Dr. Torfgård was with AstraZeneca, where she worked for several years in the clinical organization in various senior and global leadership roles. In particular, at different times she was responsible for the gastrointestinal portfolio through Phase 2, responsible for the Established Cardiovascular Brands portfolio and led in-licensing projects and scientific collaborations. Dr. Torfgård holds a M.Sc. in Pharmacy and a Ph.D. in Clinical Pharmacology.
Research Interest
Cardiovascular and metabolic disease/diabetes
